en
fr

Topics

Biologics + Biosimilars
Cardiovascular Disease
Colorectal Cancer
Multiple Myeloma
Osteoporosis
Rheumatoid Arthritis
All Posts

Featured Content

Osteoporosis can be deadly. Are you at risk?
How healthy are your bones?
Is your osteoporosis treatment right for you?
Know your fracture risk.

Subscribe

Get our newsletter

Today's biotechnology industry moves at light speed. Subscribe today for the latest news alerts and more.

* indicates required

Province:

Preferred Language:

English
French

I'm interested in learning about:

Biologics & Biosimilars
Cardiovascular Disease
Colorectal Cancer
Multiple Myeloma
Osteoporosis
Rheumatoid Arthritis
All topics

I’ve read and accept the Privacy Policy.* By checking this box, I agree that representatives of Amgen Canada Inc. (“Amgen”) may communicate with me via electronic means such as email and text message, for the purposes of providing me with newsletters and self-surveys related to the content of the website located at https://www.thebiotechnologist.ca/ (the “Biotechnologist Website”). At any time, I will have the opportunity to opt-out from such electronic communications by providing notice to Amgen at 6775 Financial Drive, Suite 100, Mississauga, Ontario L5N 0A4, by visiting http://cp.amgen.ca or by following the instructions included in each communication.*

The Biotechnologist is an online magazine that captures perspectives on science, innovation and the future of medicines.

Privacy Statement | Terms of Use

Subscribe to newsletter

Stay connected to our latest news and more.

Subscribe

The Biotechnologist is an online magazine that captures perspectives on science, innovation and the future of medicines.

Privacy Statement | Terms of Use